Outlook Therapeutics launches public offering; shares down [Seeking Alpha]
Outlook Therapeutics, Inc. (OTLK)
Last outlook therapeutics, inc. earnings: 2/14 08:00 am
Check Earnings Report
Company Research
Source: Seeking Alpha
The offering may include pre-funded warrants in place of common stock. The offering size and terms are not yet finalized. Proceeds will primarily be used for working capital and general corporate purposes. OTLK shares down nearly 22% post-market. Fresh Stock Ideas, Every Day Explore diverse investing perspectives with daily analysis from experts across the market. Subscribe to Stock Ideas Sign Up More on Outlook Therapeutics Third Time's The Charm: Outlook Therapeutics' Lytenava Heads To FDA, Again Outlook Therapeutics drops 80% on CRL for BLA for wet AMD asset Seeking Alpha's Quant Rating on Outlook Therapeutics Historical earnings data for Outlook Therapeutics Financial information for Outlook Therapeutics
Show less
Read more
Impact Snapshot
Event Time:
OTLK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OTLK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OTLK alerts
High impacting Outlook Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
OTLK
News
- Outlook Therapeutics Announces Closing of $5.0 Million Public OfferingGlobeNewswire
- Outlook Therapeutics Announces Pricing of $5.0 Million Public OfferingGlobeNewswire
- Outlook Therapeutics Announces Proposed Public Offering [Yahoo! Finance]Yahoo! Finance
- Outlook Therapeutics Announces Proposed Public OfferingGlobeNewswire
- Outlook Therapeutics Announces New $18.4 Million Non-Convertible Note Financing and Amendment to Existing Convertible Note [Yahoo! Finance]Yahoo! Finance
OTLK
Earnings
- 2/17/26 - Miss
OTLK
Sec Filings
- 3/25/26 - Form 8-K
- 3/25/26 - Form 424B5
- 3/23/26 - Form 424B5
- OTLK's page on the SEC website